Testing Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for ccRCC (NEO RoBOT)
This phase II trial tests the effect of botensilimab and balstilimab before surgery (neoadjuvant) in treating patients with high-risk clear cell renal cell cancer that has not spread from where it first started to other areas of the body…
- Investigator
- Daniel V Araujo
- Status
- Accepting Candidates
- Ages
- Adults
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, pembrolizumab, cabozantinib, and lenvatinib, to SOC immunotherapy alone in treating…
- Investigator
- Daniel V Araujo
- Status
- Accepting Candidates
- Ages
- Adults
- Sexes
- All